Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Long-Term Debt Repayments (2016 - 2017)

Palisade Bio (PALI) has disclosed Long-Term Debt Repayments for 5 consecutive years, with $2.5 million as the latest value for Q2 2017.

  • On a quarterly basis, Long-Term Debt Repayments rose 125.24% to $2.5 million in Q2 2017 year-over-year; TTM through Dec 2017 was $3.8 million, a 17.59% decrease, with the full-year FY2017 number at $3.8 million, down 17.59% from a year prior.
  • Long-Term Debt Repayments was $2.5 million for Q2 2017 at Palisade Bio, up from $1.2 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $2.5 million in Q2 2017 to a low of $12096.0 in Q4 2014.
  • A 4-year average of $1.0 million and a median of $1.1 million in 2016 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: surged 9441.58% in 2015, then grew 2.9% in 2016.
  • Palisade Bio's Long-Term Debt Repayments stood at $12096.0 in 2014, then soared by 9441.58% to $1.2 million in 2015, then rose by 2.9% to $1.2 million in 2016, then surged by 114.13% to $2.5 million in 2017.
  • Per Business Quant, the three most recent readings for PALI's Long-Term Debt Repayments are $2.5 million (Q2 2017), $1.2 million (Q1 2017), and $1.2 million (Q4 2016).